The trading price of Abbvie Inc (NYSE:ABBV) floating lower at last check on Wednesday, April 24, closing at $168.17, -0.81% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 61.82. In examining the 52-week price action we see that the stock hit a 52-week high of $182.89 and a 52-week low of $130.96. Over the past month, the stock has lost -5.80% in value.
Abbvie Inc, whose market valuation is $297.78 billion at the time of this writing. The dividend yield on the company stock is 3.60%, while its Forward Dividend ratio is 6.06. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 2.23 per share this quarter, however they have predicted annual earnings per share of 11.1 for current year and 12.15 for next year.
Analysts have forecast the company to bring in revenue of 11.92B for the current quarter, with the likely lows of 11.86B and highs of 11.98B. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 54.6B.
On the technical side, indicators suggest ABBV has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 9.75, which symbolizes a positive outlook. A quick review shows that ABBV’s price is currently -1.48% off the SMA20 and -3.91% off the SMA50. The RSI metric on the 14-day chart is currently showing 44.73, and weekly volatility stands at 1.54%. When measured over the past 30 days, the indicator reaches 1.80%. Abbvie Inc (NYSE:ABBV)’s beta value is currently sitting at 0.58, while the Average True Range indicator is currently displaying 3.20.
To see how Abbvie Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: ABBV stock’s performance was -0.81% at last check in today’s session, and 2.49% in the past year. Abbvie Inc has a P/E ratio of 61.82.
An evaluation of the daily trading volume of Abbvie Inc (NYSE:ABBV) indicates that the 3-month average is 5.62 million.
Currently, records show that 1.77 billion of the company’s shares remain outstanding. The insiders hold 0.11% of outstanding shares, whereas institutions hold 71.76%. However, since the stock’s price has seen 8.52% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
